Sloan Sheldon bought SYRE
July 1, 2026 · Form 4 insider transaction
Sloan Sheldon bought 8,334 shares of Spyre Therapeutics, Inc. at $27.46 per share, a transaction worth $228.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,334
Price
$27.46
Total value
$228.9K
InsiderSloan Sheldon
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after8,334
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.